GNH USA

Europe — EMA

Apretude

Apretude is an injectable medication used for HIV prevention. It contains cabotegravir and is administered intramuscularly. Learn more about its uses and effect

Cabotegravir

Request sourcing

1
Pack/s

What is Cabotegravir?

Apretude is an injectable medication used for HIV prevention. It contains cabotegravir and is administered intramuscularly. Learn more about its uses and effects.

What is Cabotegravir used for?

Apretude is primarily used for HIV pre-exposure prophylaxis (PrEP) in adults at risk of HIV infection. It is a long-acting injectable medication designed to prevent HIV infection when taken as prescribed. Apretude is not a cure for HIV but helps reduce the risk of contracting the virus.

What are the side effects of Cabotegravir?

Common effects of Apretude may include injection site reactions, such as pain, swelling, or redness. Some individuals may experience headaches, fever, or fatigue. These effects are generally mild and temporary.

What precautions apply to Cabotegravir?

Apretude should be used under medical supervision. It is important to discuss any allergies or medical conditions with your healthcare provider before starting treatment. Regular monitoring may be required to ensure the medication's effectiveness and safety.

What does Cabotegravir interact with?

Apretude may interact with certain medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be discussed with your healthcare provider.

Frequently asked questions

What is Apretude used for?+
Apretude is used for HIV pre-exposure prophylaxis (PrEP) to reduce the risk of HIV infection in adults at risk.
How is Apretude administered?+
Apretude is administered intramuscularly by a healthcare professional.
What are the common side effects of Apretude?+
Common side effects may include injection site reactions, headaches, fever, and fatigue.
Can Apretude be used to treat HIV?+
No, Apretude is not a treatment for HIV but is used for prevention in individuals at risk.
How often is Apretude administered?+
Apretude is typically administered every two months after an initial dosing schedule.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Cabotegravir
Route
Intramuscular Use
Manufacturer
Viiv Healthcare B.V.
Origin
EU

Related products